Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PPH vs. FPHAX: which is better?

Bottom line

PPH vs FPHAX: the short answer

PPH (VanEck Pharmaceutical ETF) and FPHAX (Pharmaceuticals Portfolio) share a meaningful slice of their top holdings — about 41% by weight.

But FPHAX is far broader, holding 57 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.

PPH is cheaper at 0.36% vs 0.67% — a difference of $31 a year per $10,000 invested.

Over five years, FPHAX returned +12.6% a year vs +11.3% for PPH (reporting dates differ).

Updated Nov 19, 2026

PPH vs FPHAX side by side

PPHFPHAX
TypeETFMutual fund
Fund familyVanEckFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.36%0.67%
Annual cost per $10k$36$67
10-yr cost on $10k (prospectus)$456$835
Max front loadNone—
12b-1 fee—0%
1-yr return+21.9%+30.3%
5-yr return (annualized)+11.3%+12.6%
10-yr return (annualized)+6.7%+10.0%
Best quarter+16.5%+18.5%
Worst quarter−15.0%−13.6%
Net assets (fund)$879.5M$1.5B
Number of holdings2657
Portfolio turnover3%77%
Returns as ofDec 31, 2025Apr 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPPHFPHAXDifference
2025+21.9%+30.3%−8.4%
2024+8.1%+9.4%−1.3%
2023+6.9%+12.5%−5.6%
2022+2.6%+1.0%+1.7%
2021+18.3%+11.8%+6.5%
2020+5.2%+11.1%−5.9%
2019+19.1%+31.6%−12.5%
2018−5.7%+5.8%−11.5%
2017+15.4%+10.7%+4.7%
2016−17.8%−16.3%−1.5%

Source: Fund prospectus bar charts

Holdings overlap

9 of PPH's top 25 holdings also appear in FPHAX's top 25.

Shared top holdings
HoldingPPHFPHAX
Eli Lilly & Co20.23%28.78%
Merck & Co Inc9.85%4.74%
Gsk Plc4.42%8.17%
Johnson & Johnson4.35%3.77%
AstraZeneca PLC4.33%4.22%
Viatris Inc1.10%5.45%
Jazz Pharmaceuticals PLC1.08%4.09%
Axsome Therapeutics Inc0.77%1.08%
Elanco Animal Health Inc0.35%4.15%

Source: SEC Form N-PORT

PPH top 10

  1. Eli Lilly & Co — 20.23%
  2. Novartis AG — 10.63%
  3. Merck & Co Inc — 9.85%
  4. Novo Nordisk A/S — 5.37%
  5. AbbVie Inc — 4.57%
  6. Pfizer Inc — 4.51%
  7. Bristol-Myers Squibb Co — 4.47%
  8. Gsk Plc — 4.42%
  9. Johnson & Johnson — 4.35%
  10. AstraZeneca PLC — 4.33%

FPHAX top 10

  1. ELI LILLY and CO — 28.78%
  2. Gsk Plc — 8.17%
  3. Viatris Inc — 5.45%
  4. Ucb Sa — 5.09%
  5. MERCK and CO INC — 4.74%
  6. Roche Holding Ag — 4.54%
  7. Legend Biotech Corp — 4.53%
  8. Astrazeneca Plc — 4.22%
  9. Elanco Animal Health Inc — 4.15%
  10. Jazz Pharmaceuticals Plc — 4.09%

FAQ

What is the difference between PPH and FPHAX?
PPH (VanEck Pharmaceutical ETF) and FPHAX (Pharmaceuticals Portfolio) share a meaningful slice of their top holdings — about 41% by weight. But FPHAX is far broader, holding 57 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.
Which is cheaper, PPH or FPHAX?
PPH has the lower expense ratio (0.36%).
Should I own both PPH and FPHAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.